跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,442 条关于
“TTR-related amyloidosis”
全部
40,442
临床试验
28,960
药物
716
机构
108
资讯
10,658
2年前
Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts
去年
Alnylam's Nucresiran Shows Sustained TTR Reduction in Phase 1 ATTR Amyloidosis Trial
去年
Alnylam's Nucresiran Shows Sustained TTR Reduction in Phase 1 ATTR Amyloidosis Trial
去年
Alnylam's Nucresiran Shows Sustained TTR Knockdown in Phase 1 ATTR Amyloidosis Trial
去年
Alnylam's Nucresiran Shows Sustained TTR Knockdown in Phase 1 Trial, Poising for Biannual Dosing in ATTR Amyloidosis
去年
Alnylam's Nucresiran Shows Sustained TTR Reduction in Phase 1 ATTR Amyloidosis Trial
去年
Intellia's Nexiguran Ziclumeran Shows Promising Phase 1 Results in ATTR Amyloidosis
去年
Intellia's CRISPR Therapy Nex-z Shows Promise in ATTR Amyloidosis Phase 1 Trial
去年
Alnylam's Nucresiran Shows Promise in Phase I Trial for ATTR Amyloidosis
去年
Intellia's CRISPR Therapy Nexiguran Ziclumeran Shows Promise in ATTR Amyloidosis Phase 1 Trial
第 1 页,共 1066 页
上一页
下一页